Evidence-Based Complementary and Alternative Medicine

Therapies of Traditional Chinese Medicine for Cardiovascular Diseases 2021


Publishing date
01 Mar 2022
Status
Published
Submission deadline
05 Nov 2021

Lead Editor

1North China University of Science and Technology, Tangshan, China

2Beijing University of Chinese Medicine, Beijing, China

3Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China

4Hong Kong Polytechnic University, Hong Kong

5Mayo Clinic, Rochester, USA


Therapies of Traditional Chinese Medicine for Cardiovascular Diseases 2021

Description

Cardiovascular diseases (CVDs), including coronary heart disease, cerebrovascular disease, and heart failure, are the leading causes of death worldwide. In 2016, an estimated 17.9 million people died from CVDs, accounting for 31% of all global deaths. Recent reports on CVDs in China indicate that the prevalence and mortality of CVDs are still on the rise. The estimated number of people suffering from CVDs in China alone is 290 million, and the death rate of CVDs still ranks as first, accounting for more than 40% of deaths across the population. In recent years, the death rate of CVDs in rural areas has been shown to be higher than that in urban areas. The total cost of hospitalization for CVDs is also increasing rapidly, with the annual growth rate much higher than the GDP growth rate. The increasing burden of CVDs has become a major public health problem, and as such there is an urgent need to prevent and treat CVDs.

Although some recent reviews have suggested that Traditional Chinese Medicine (TCM) may benefit some heart disease patients and TCM treatment of diseases has indeed been recognized by patients, there is a lack of evidence-based research in line with the requirements of modern medical science. The exact mechanisms of the actions of TCM also need to be explained by scientific data, and so expert attention is needed to support the clinical value and effectiveness of TCM in treating CVDs.

The aim of this Special Issue is to collate results from the following aspects including safety of TCM therapies, side effects, clinical trials, and practice, to enrich the current knowledge of the efficacy of TCM therapies in treating CVDs. We invite researchers to contribute original research articles as well as review articles that will assess the roles of TCM therapies for CVDs.

Potential topics include but are not limited to the following:

  • In vivo or in vitro study to explore the exact mechanism of TCM therapies for CVDs
  • Recent development in TCM therapies for CVDs
  • Randomized clinical trials of TCM therapies for CVDs
  • Systematic review and/or meta-analysis of TCM therapies for CVDs
  • Toxicological effects associated with the use of TCM therapies for CVDs
  • Clinical practice of TCM therapies with conventional medicines and western medicine for CVDs
  • Perspective or commentary articles on TCM therapies for CVDs
  • Perspective or commentary articles on TCM therapies for CVDs and its complications

Articles

  • Special Issue
  • - Volume 2021
  • - Article ID 8583285
  • - Review Article

Advances of Traditional Chinese Medicine Regulating Connexin43 in the Prevention and Treatment of Myocardial Infarction

Keke Liu | Meng Lv | ... | Mingjing Zhao
  • Special Issue
  • - Volume 2021
  • - Article ID 4532279
  • - Research Article

Toward the Development of Personalized Syndrome Discriminant Systems: A Discriminant System for Hypertension with Liver Yang Hyperactivity Syndrome

Guang-yao Shang | Lei Zhang | ... | Wen-qing Yang
  • Special Issue
  • - Volume 2021
  • - Article ID 7375549
  • - Research Article

Wenxin Granules Regulate Endoplasmic Reticulum Stress Unfolded Protein Response and Improve Ventricular Remodeling on Rats with Myocardial Infarction

Keke Liu | Meng Lv | ... | Mingjing Zhao
  • Special Issue
  • - Volume 2021
  • - Article ID 5582567
  • - Research Article

FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model

Lexun Wang | Huijuan Wu | ... | Jiao Guo
  • Special Issue
  • - Volume 2021
  • - Article ID 2252832
  • - Research Article

Immune Mechanism, Gene Module, and Molecular Subtype Identification of Astragalus Membranaceus in the Treatment of Dilated Cardiomyopathy: An Integrated Bioinformatics Study

Xiao-yang Chen | Hong-fei Han | ... | Xue-gong Xu
  • Special Issue
  • - Volume 2021
  • - Article ID 4094325
  • - Research Article

Tai Chi as a Therapy of Traditional Chinese Medicine on Reducing Blood Pressure: A Systematic Review of Randomized Controlled Trials

Xiandu Pan | Li Tian | ... | Yanwei Xing
  • Special Issue
  • - Volume 2021
  • - Article ID 9988650
  • - Research Article

Exploring the Biological Mechanism of Huang Yam in Treating Tumors and Preventing Antitumor Drug-Induced Cardiotoxicity Using Network Pharmacology and Molecular Docking Technology

Hui Zhang | Wenchao Dan | ... | Xinyuan Guo
  • Special Issue
  • - Volume 2021
  • - Article ID 7439852
  • - Research Article

A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Effect of Qishen Yiqi Dripping Pills on Exercise Endurance and Quality of Life in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention

Linghua Yu | Xiaoyan Lu | ... | Cheng Xiao
  • Special Issue
  • - Volume 2021
  • - Article ID 5168574
  • - Research Article

Effects of Yiqi Huoxue Decoction on Post-Myocardial Infarction Cardiac Nerve Remodeling and Cardiomyocyte Hypertrophy in Rats

Hui Wang | Yuqin Zhang | ... | Yufei Li
  • Special Issue
  • - Volume 2021
  • - Article ID 4280482
  • - Research Article

Identification of Potential Bioactive Ingredients and Mechanisms of the Guanxin Suhe Pill on Angina Pectoris by Integrating Network Pharmacology and Molecular Docking

Mingmin Wang | Shuangjie Yang | ... | Wei Wang
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.